ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!Tactile Systems Technology, Inc. (TCMD) stock declined over -2.78%, trading at $14.95 on NASDAQ, down from the previous close of $15.38. The stock opened at $15.34, fluctuating between $14.90 and $15.51 in the recent session.
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Employees | 992 |
Beta | 1.21 |
Sales or Revenue | $274.42M |
5Y Sales Change% | 0.611% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |
Tactile Systems Technology, Inc. (NASDAQ: TCMD) stock price is $14.95 in the last trading session. During the trading session, TCMD stock reached the peak price of $15.51 while $14.90 was the lowest point it dropped to. The percentage change in TCMD stock occurred in the recent session was -2.78% while the dollar amount for the price change in TCMD stock was -$0.43.
The NASDAQ listed TCMD is part of Medical - Devices industry that operates in the broader Healthcare sector. Tactile Systems Technology, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Jerry A. Sauber
Senior Vice President of Manufacturing, Operations, R&D
Dr. Antonios P. Gasparis F.A.C.S., M.D.
Chief Medical Officer & Member of Vascular Strategic Advisory Board
Mr. Daniel L. Reuvers
Pres, Chief Executive Officer & Director
Ms. Kristie T. Burns
Senior Vice President of Marketing & Clinical Affairs
Mr. John David Kaercher
Chief Information Officer
Janelle M. Strop
Chief Human Resource Officer
Ms. Sunday J. Hoy
Vice President & Compliance Officer
Mr. Peter C. Schaubach
Chief Information Officer
Janelle Strop
Chief Human Resource Officer
Mr. Eric C. Pauls
Senior Vice President of Sales
Mr. Brent A. Moen
Chief Financial Officer
Ms. Sunday J. Hoy Esq.
Vice President & Compliance Officer
Mr. Thomas F. O'Donnell Jr., M.D.
Chief Medical Officer & Member of Vascular Strategic Advisory Board
Ms. Elaine Birkemeyer
Chief Financial Officer
Ms. Elaine M. Birkemeyer
Chief Financial Officer
Mickey D. Brown
Senior Vice President of Payer Relations & Market Access
Ms. Sherri Ferstler
Senior Vice President of Sales
Rachel L. Gustad
Senior Vice President of Commercial Operations
TCMD's closing price is 38.31% higher than its 52-week low of $11.12 where as its distance from 52-week high of $21.10 is -27.11%.
Number of TCMD employees currently stands at 992.
Official Website of TCMD is: https://www.tactilemedical.com
TCMD could be contacted at phone 612 355 5100 and can also be accessed through its website. TCMD operates from 3701 Wayzata Boulevard, Minneapolis, MN 55416, United States.
TCMD stock volume for the day was 312.77K shares. The average number of TCMD shares traded daily for last 3 months was 310.14K.
The market value of TCMD currently stands at $352.67M with its latest stock price at $14.95 and 23.59M of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com